BIOVIE INC.
No SEC Form 4 filings for $BIVI in the last 30 days.
This article identifies top gapping stocks on Tuesday, categorizing them into "gap up" and "gap down" groups. It provides specific details for each stock listed, including percentage change, gap percentage, stock price, and relevant news like earnings releases or press statements.
Faruqi & Faruqi, LLP, a national securities law firm, is investigating potential claims against BioVie Inc. (NASDAQ: BIVI) and reminds investors of the March 19, 2024 deadline to seek the role of lead plaintiff in a federal securities class action. The investigation follows a significant drop in BioVie's stock price after the company disclosed issues with its Phase 3 clinical trial for Alzheimer's disease, including significant protocol deviations and Good Clinical Practice violations leading to patient exclusions. Investors who suffered losses exceeding $25,000 between August 5, 2021, and November 29, 2023, are encouraged to contact the firm.
New to The Street will broadcast Show #716 tonight at 6:30 PM ET on Bloomberg Television, featuring companies Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), and Roadzen (NASDAQ:RDZN). The episode will also include special segments with Kelsey Grammer discussing his book "KAREN" and Andrew Shaw from 250DAYS.ORG. This broadcast is sponsored programming supported by national commercials from several companies, highlighting New to The Street's "Predictable Media" model.
